Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer.

Advances in dental research

Volumn 12, Issue 2, 1998, Pages 97-102

  Lokeshwar, B L ^a   Houston Clark, H L ^a   Selzer, M G ^a   Block, N L ^a   Golub, L M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE; FLURBIPROFEN; METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEINASE INHIBITOR; TETRACYCLINE CMT 3; TETRACYCLINE CMT-3; TETRACYCLINE DERIVATIVE;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; ENZYMOLOGY; EPITHELIUM CELL; HUMAN; LUNG TUMOR; MALE; METASTASIS; PATHOLOGY; PROSTATE TUMOR; RAT; REGRESSION ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CELL DIVISION; DOXYCYCLINE; DRUG INTERACTIONS; EPITHELIAL CELLS; FLURBIPROFEN; HUMANS; LUNG NEOPLASMS; MALE; METALLOENDOPEPTIDASES; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS; RATS; REGRESSION ANALYSIS; TETRACYCLINES; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0032198323     PISSN: 08959374     EISSN: None     Source Type: Journal    
DOI: 10.1177/08959374980120012901     Document Type: Article

References (0)